Furutal et al reported that the combination of an FASN inhibitor with cyclophosphamide partially overcame the drug resistance caused by tumor hypoxia, suggesting that FASN inhibition may improve the efficiency of chemotherapy.222. This evidence concerns the gene FASN and neoplasm.